These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12962343)

  • 1. Design and development of a coronary heart disease decision support tool.
    Brekke MJ; Kottke TE; Brekke LN; Wu LA
    Int J Technol Assess Health Care; 2003; 19(3):555-8. PubMed ID: 12962343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular ultrasound-guided interventions in coronary artery disease: a systematic literature review, with decision-analytic modelling, of outcomes and cost-effectiveness.
    Berry E; Kelly S; Hutton J; Lindsay HS; Blaxill JM; Evans JA; Connelly J; Tisch J; Walker GC; Sivananthan UM; Smith MA
    Health Technol Assess; 2000; 4(35):1-117. PubMed ID: 11109031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCI Choice Decision Aid for Stable Coronary Artery Disease: A Randomized Trial.
    Coylewright M; Dick S; Zmolek B; Askelin J; Hawkins E; Branda M; Inselman JW; Zeballos-Palacios C; Shah ND; Hess EP; LeBlanc A; Montori VM; Ting HH
    Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):767-776. PubMed ID: 27803090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillation in patients subjected to coronary artery bypass grafting.
    Wu ZK; Iivainen T; Pehkonen E; Laurikka J; Zhang S; Tarkka MR
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1477-82. PubMed ID: 14666022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.
    Bonzel T; Schächinger V; Dörge H
    Clin Res Cardiol; 2016 May; 105(5):388-400. PubMed ID: 26508415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and in-hospital outcomes of acute kidney injury that developed after coronary artery bypass grafting in patients with stable angina.
    Kremneva LV; Suplotov SN
    Ter Arkh; 2018 Sep; 90(9):48-52. PubMed ID: 30701735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary interventions: guidelines, short- and long-term results, and comparison with coronary artery bypass grafting.
    Cigarroa JE; Hillis LD
    Cardiol Clin; 2006 May; 24(2):255-63, vii. PubMed ID: 16781942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
    Capewell S; Morrison CE; McMurray JJ
    Heart; 1999 Apr; 81(4):380-6. PubMed ID: 10092564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting.
    Mathew V; Wilson SH; Barsness GW; Frye RL; Lennon R; Holmes DR
    Eur Heart J; 2002 Sep; 23(18):1456-64. PubMed ID: 12208226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving quality indicator benchmarks and potential impact on coronary heart disease mortality.
    Wijeysundera HC; Mitsakakis N; Witteman W; Paulden M; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
    Can J Cardiol; 2011; 27(6):756-62. PubMed ID: 21920697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass grafting versus percutaneous intervention in heart failure.
    Barker AP; Nashef SA
    Scand J Surg; 2007; 96(2):107-10. PubMed ID: 17679351
    [No Abstract]   [Full Text] [Related]  

  • 15. Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris.
    Fukui T; Tabata M; Morita S; Takanashi S
    J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1577-83, 1583.e1. PubMed ID: 22704288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy or coronary artery bypass graft surgery for chronic stable angina: an update using decision analysis.
    Kwok YS; Kim C; Heidenreich PA
    Am J Med; 2001 Aug; 111(2):89-95. PubMed ID: 11498060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group.
    Mangano DT; Browner WS; Hollenberg M; Li J; Tateo IM
    JAMA; 1992 Jul; 268(2):233-9. PubMed ID: 1608143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty.
    Posner KL; Van Norman GA; Chan V
    Anesth Analg; 1999 Sep; 89(3):553-60. PubMed ID: 10475280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.